Refine by
Oncology Suppliers In Usa Texas
10 companies found
based inIrving, TEXAS (USA)
Celanese (NYSE: CE) is a global chemical and specialty materials company that engineers and manufactures a wide variety of products essential to everyday living. Celanese is built on the tradition of using our expertise – chemical intermediates, ...
based inDallas, TEXAS (USA)
Lupagen is a privately held early stage biotech company developing first-in-class bedside enabled cell & gene therapies (CAR-T cell, gene editing and immunotherapy products) based on their patent-pending bedside point-of-care C and GT production and ...
Lupagen avoids the cost & complexity of cell therapy and the safety & clinical challenges of viral-based gene therapy by a simple patient-connected gene delivery procedure done at the bedside. Our Side CAR-T® delivery system, a ...
based inNew Castle, DELAWARE (USA)
Nixon Medical is the leading service provider of medical apparel and linens serving outpatient healthcare centers. From trusted Nixon laundry services to reliable Nixon customer service, the management of your medical apparel and linens will thrive ...
based inFrisco, TEXAS (USA)
Argon Medical is a global manufacturer of specialty medical products, headquartered in Frisco, Texas. Argon offers a broad line of medical devices for Interventional Radiology, Vascular Surgery, Interventional Cardiology and Oncology. Argon’s ...
based inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Covered by Medicare, Prospera is a transplant rejection assessment test that uses a simple blood draw to evaluate the risk of rejection of a transplanted kidney. Through the use of advanced cell-free DNA technology, Prospera increases a ...
based inSeguin, TEXAS (USA)
Cone Bioproducts is a premiere manufacturer of In-Vitro Diagnostic quality controls and components. We leverage our experience in handling human and animal biologicals to extend our offerings across the healthcare and life sciences industries - ...
based inSan Antonio, TEXAS (USA)
Surgilogix is a leading provider of human tissue allografts that support surgeons and physicians in their efforts to improve their patients’ quality of life. Our amniotic tissue allografts are used to cover and protect wounds and our allograft bone ...
SXDBM is an advanced healing technology that is revolutionizing the way doctors approach bone defects. This unique human allograft tissue is derived from human bone which has undergone a specialized demineralization process that maintains the ...
based inAustin, TEXAS (USA)
Asuragen a Bio-Techne brand is a molecular diagnostic product company changing the way patients are treated in genetics and oncology. Asuragen’s diagnostic systems, composed of proprietary chemistry and software, deliver powerful answers using ...
The QuantideX® qPCR BCR-ABL minor Kit (RUO) is a clinical research tool enabling ultra-sensitive and precise detection of BCR-ABL1 minor fusion transcripts (e1a2) from whole blood specimens. Building on the simple workflow and best-in-class ...
based inFriendswood, TEXAS (USA)
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and ...
Uveal melanoma, commonly known as ocular or choroidal melanoma, is a rare cancer of the eye with approximately 2,000 patients diagnosed annually in the U.S. At the time of initial diagnosis, approximately 97% of patients are free of metastasis. ...
based inBryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
Advances in the field of immuno-oncology have led to new and better treatment outcomes for a range of cancers, and particularly, blood cancers. However, even with the advent of checkpoint inhibitors as immunotherapies for solid ...